Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.160
-0.030 (-2.52%)
At close: Oct 30, 2026, 4:00 PM EDT
1.180
+0.020 (1.72%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $202.15 million as of October 30, 2026. It is the 20,489th most valuable company in the world and the 3,559th biggest in the United States. Its market cap has decreased by 28.31% in one year.
Market Cap
202.15M
Enterprise Value
76.98M
1-Year Change
-28.31%
Global Rank
Country Rank
#3,559 United States
Category
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $202.15M, an increase of 169.29%. That is a compound annual growth rate of 19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 202.15M | -42.27% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 216.22M |
| Korro Bio | 210.80M |
| BridgeBio Oncology Therapeutics | 210.06M |
| Protalix BioTherapeutics | 208.68M |
| Artiva Biotherapeutics | 204.85M |
| Cartesian Therapeutics | 196.36M |
| ProQR Therapeutics | 196.16M |
| Precision BioSciences | 194.87M |